While the top- and bottom-line numbers for Kamada (KMDA) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
While the top- and bottom-line numbers for Kamada (KMDA) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Kamada (KMDA) delivered earnings and revenue surprises of +7.69% and -2.76%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of +211.77% and +37.23%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
A substantial insider move unfolded on September 29, as Topilsky, Director at Kamada (NASDAQ:KMDA), reported the acquisition of stock options for 86,500 shares in an SEC filing.
What Happened: A Form 4 filing from theread more...
In a recent SEC filing, it was disclosed that Ishay Davidi, Board Member at Kamada (NASDAQ:KMDA), made a noteworthy acquisition of company stock options on September 29,.
What Happened: Davidi, Board Member at Kamada,read more...
In a new SEC filing on September 29, it was unveiled that Botzer, Board Member at Kamada (NASDAQ:KMDA), acquired stock options for 60,000 shares.
What Happened: In a recent Form 4 filing with the U.S. Securities andread more...
A notable acquisition unfolded on September 29, as Davidi, Board Member at Kamada (NASDAQ:KMDA), reported the acquisition of stock options for 86,500 shares in an SEC filing.
What Happened: Davidi, Board Member atread more...
Disclosed in a recent SEC filing, Lilach Asher Topilsky, Director at Kamada (NASDAQ:KMDA), made a strategic move by acquiring company stock options on September 29,.
What Happened: Disclosed in a Form 4 filing onread more...
A notable acquisition unfolded on September 29, as Botzer, Board Member at Kamada (NASDAQ:KMDA), reported the acquisition of stock options for 60,000 shares in an SEC filing.
What Happened: A Form 4 filing from the U.S.read more...
A substantial insider move unfolded on September 25, as London, Chief Executive Officer at Kamada (NASDAQ:KMDA), reported the acquisition of stock options for 800,000 shares in an SEC filing.
What Happened: In a Form 4read more...